Vimarsana
Biggest News Aggregation in the World

Nasdaq Hcat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Hcat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Hcat Today - Breaking & Trending Today

KeyCorp Cuts Health Catalyst (NASDAQ:HCAT) Price Target to $10.00 - Vimarsana News

KeyCorp Cuts Health Catalyst (NASDAQ:HCAT) Price Target to $10.00

Health Catalyst (NASDAQ:HCAT – Free Report) had its target price lowered by KeyCorp from $12.00 to $10.00 in a research report released on Monday morning, Benzinga reports. The firm currently has an overweight rating on the stock. A number of other research firms have also weighed in on HCAT. Guggenheim upgraded shares of Health Catalyst […]

Source: wkrb13.com
Canaccord Genuity Group Trims Health Catalyst (NASDAQ:HCAT) Target Price to $11.00 - Vimarsana News

Canaccord Genuity Group Trims Health Catalyst (NASDAQ:HCAT) Target Price to $11.00

Health Catalyst (NASDAQ:HCAT – Free Report) had its target price lowered by Canaccord Genuity Group from $12.00 to $11.00 in a report issued on Friday morning, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Several other brokerages have also weighed in on HCAT. Stifel Nicolaus dropped their price objective on […]

Source: wkrb13.com
Health Catalyst Reports Fourth Quarter and Year End 2023 - Vimarsana News

Health Catalyst Reports Fourth Quarter and Year End 2023

SOUTH JORDAN, Utah., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (

Health Catalyst, Inc. (NASDAQ:HCAT) Given Consensus Recommendation of "Moderate Buy" by Analysts - Vimarsana News

Health Catalyst, Inc. (NASDAQ:HCAT) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) have been given an average recommendation of “Moderate Buy” by the thirteen research firms that are presently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average […]

Bank of New York Mellon Corp Has $8.65 Million Stock Holdings in Health Catalyst, Inc. (NASDAQ:HCAT) - Vimarsana News

Bank of New York Mellon Corp Has $8.65 Million Stock Holdings in Health Catalyst, Inc. (NASDAQ:HCAT)

Bank of New York Mellon Corp lifted its position in Health Catalyst, Inc. (NASDAQ:HCAT – Free Report) by 124.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 854,896 shares of the company’s stock after acquiring an additional 473,323 shares during the period. […]